Engineered nanoparticle-induced epigenetic changes: An important consideration in nanomedicine
Source abstract
Abstract
Engineered nanoparticles (ENPs) are now being applied across a range of disciplines, and as a result numerous studies have now assessed ENP-related bioeffects. Among them, ENP-induced epigenetic changes including DNA methylation, histone modifications, and miRNA-mediated regulation of gene expression have recently attracted attention. In this review, we describe the diversity of ENP-induced epigenetic changes, focusing on their interplay with related functional biological events, especially oxidative stress, MAPK pathway activation, and inflammation. In doing so, we highlight the underlying mechanisms and biological effects of ENP-induced epigenetic changes. We also summarize how high-throughput technologies have helped to uncover ENP-induced epigenetic changes. Finally, we discuss future perspectives and the challenges related to ENP-induced epigenetic changes that still need to be addressed.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: MicroRNA in disease regulation · Epigenetics and DNA Methylation · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Considerations on the EU definition of a nanomaterial: science to support policy making10.1016/j.yrtph.2012.11.007 ↗
2. Nanomedicine10.1056/NEJMra0912273 ↗
3. Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies10.2217/nnm-2017-0043 ↗
4. Nanomaterials innovation as an enabler for effective cancer interventions10.1016/j.biomaterials.2020.119926 ↗
5. Application of nanodiagnostics and nanotherapy to CNS diseases10.2217/nnm-2018-0163 ↗
6. Gold nanoparticles in cancer treatment10.1021/acs.molpharmaceut.8b00810 ↗
7. Gold nanoparticles for tracking bacteria clearance by regulated irrigation and negative pressure-assisted wound therapy10.2217/nnm-2018-0053 ↗
8. Nano-bio effects: interaction of nanomaterials with cells10.1039/c3nr34276j ↗
9. Mechanisms of nanoparticle-induced oxidative stress and toxicity
10. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy10.1021/acs.chemrev.5b00148 ↗
11. Prasad · 2012
12. Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance10.1016/j.drup.2017.05.002 ↗
13. Versatile types of organic/inorganic nanohybrids: from strategic design to biomedical applications10.1021/acs.chemrev.8b00401 ↗
14. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future10.1039/c2cs15355f ↗
15. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles10.1021/nn800507t ↗
16. Multifunctionality of gold nanoparticles: plausible and convincing properties10.1016/j.cis.2019.101989 ↗
17. Nanosilver as a new generation of nanoproduct in biomedical applications10.1016/j.tibtech.2010.07.006 ↗
18. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening10.1021/ar300022h ↗
19. Nanomaterials for theranostics: recent advances and future challenges10.1021/cr300213b ↗
20. Applications of advanced hybrid organic-inorganic nanomaterials: from laboratory to market10.1039/c0cs00136h ↗
21. New generation cadmium-free quantum dots for biophotonics and nanomedicine10.1021/acs.chemrev.6b00290 ↗
22. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery10.1002/adma.201104763 ↗
23. Radiolabeling silica-based nanoparticles via coordination chemistry: basic principles, strategies, and applications10.1021/acs.accounts.7b00635 ↗
24. Carbon nanotube, graphene and boron nitride nanotube reinforced bioactive ceramics for bone repair10.1016/j.actbio.2017.05.020 ↗
25. Carbon nanomaterials in biological studies and biomedicine10.1002/adhm.201700574 ↗
26. Perspectives on the past, present, and future of cancer nanomedicine10.1016/j.addr.2018.05.008 ↗
27. A review on preparation, properties and applications of polymeric nanoparticle-based materials10.1080/03602559.2014.958780 ↗
28. Stimulus-responsive polymeric nanogels as smart drug delivery systems10.1016/j.actbio.2019.05.018 ↗
29. Lipid-based nanocarriers for oral peptide delivery10.1016/j.addr.2016.04.001 ↗
30. Liposome-chaperoned cell-free synthesis for the design of proteoliposomes: implications for therapeutic delivery10.1016/j.actbio.2018.03.043 ↗
31. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy10.1016/j.actbio.2016.05.012 ↗
32. The molecular hallmarks of epigenetic control10.1038/nrg.2016.59 ↗
33. An operational definition of epigenetics10.1101/gad.1787609 ↗
34. The significance of epigenetic alterations in lung carcinogenesis10.1007/s11033-012-2063-4 ↗
35. HMGA proteins as modulators of chromatin structure during transcriptional activation10.3389/fcell.2014.00005 ↗
36. Epigenetic modifications and human disease10.1038/nbt.1685 ↗
37. N(6)-methyladenine DNA modification in the human genome10.1016/j.molcel.2018.06.015 ↗
38. Hydroxymethylation of DNA: an epigenetic marker
39. Reversing DNA methylation: mechanisms, genomics, and biological functions10.1016/j.cell.2013.12.019 ↗
40. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation10.1038/nrg.2017.80 ↗
41. Proteins that bind methylated DNA and human cancer: reading the wrong words10.1038/sj.bjc.6604374 ↗
42. The tale of histone modifications and its role in multiple sclerosis10.1186/s40246-018-0163-5 ↗
43. Combinatorial patterns of histone acetylations and methylations in the human genome10.1038/ng.154 ↗
44. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes10.1016/j.cell.2009.06.049 ↗
45. Chromatin higher order structure: opening up chromatin for transcription10.1093/bfgp/2.4.334 ↗
46. Chromatin-remodeling for transcription10.1017/S003358351700004X ↗
47. Non-coding RNAs as direct and indirect modulators of epigenetic regulation10.4161/epi.27473 ↗
48. MicroRNAs: target recognition and regulatory functions10.1016/j.cell.2009.01.002 ↗
49. Structure and function of long noncoding RNAs in epigenetic regulation10.1038/nsmb.2480 ↗
50. and Mechanisms of long non-coding RNAs in cancer10.1016/j.gpb.2015.09.006 ↗
51. Epigenetics in cancer therapy and nanomedicine10.1186/s13148-019-0675-4 ↗
52. Grand challenge commentary: RNA epigenetics?10.1038/nchembio.482 ↗
53. Dynamic RNA modifications in gene expression regulation10.1016/j.cell.2017.05.045 ↗
54. RNA modifications regulating cell fate in cancer10.1038/s41556-019-0319-0 ↗
55. mRNA traffic control reviewed: n6-methyladenosine (m(6) A) takes the driver’s seat10.1002/bies.201700093 ↗
56. The critical role of RNA m(6)A methylation in cancer10.1158/0008-5472.CAN-18-2965 ↗
57. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer10.1016/j.ccell.2020.02.004 ↗
58. Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology10.1186/s12943-020-01159-9 ↗
59. Role of RNA modifications in cancer10.1038/s41568-020-0253-2 ↗
60. Cancer epigenetics: from mechanism to therapy10.1016/j.cell.2012.06.013 ↗
61. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies10.1016/S1474-4422(09)70262-5 ↗
62. Epigenetic control in rheumatoid arthritis synovial fibroblasts10.1038/nrrheum.2009.55 ↗
63. Epigenetic flexibility in metabolic regulation: disease cause and prevention?10.1016/j.tcb.2012.11.008 ↗
64. Epigenetic changes in diabetes and cardiovascular risk10.1161/CIRCRESAHA.116.306819 ↗
65. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism10.1002/dneu.22024 ↗
66. Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: a systematic review and meta-analysis10.1016/j.bbr.2015.08.035 ↗
67. B.K. Lee, C. Magnusson, R.M. Gardner, A. Blomstrom, C.J. Newschaffer, I. Burstyn, H. Karlsson, C. Dalman, Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders, brain, behavior, and immunity44 (2015) 100–5.10.1016/j.bbi.2014.09.001 ↗
68. Epigenetics and the environment: emerging patterns and implications10.1038/nrg3142 ↗
69. Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?10.1186/s13148-015-0130-0 ↗
70. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H1910.1086/346031 ↗
71. In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene10.1086/374824 ↗
72. Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples10.1136/jmg.2004.026930 ↗
73. The prospective role of abnormal methyl metabolism in cadmium toxicity10.1289/ehp.02110s5793 ↗
74. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults10.1093/ajcn/86.4.1179 ↗
75. Insights into the epigenetic effects of nanomaterials on cells10.1039/C9BM01526D ↗
76. Epigenetic aspects of engineered nanomaterials: is the collateral damage inevitable?10.3389/fbioe.2019.00228 ↗
77. The effect of exposure to nanoparticles and nanomaterials on the mammalian epigenome10.2147/IJN.S120104 ↗
78. Epigenetic modulations in nanoparticle-mediated toxicity10.1016/j.fct.2017.07.006 ↗
79. Epigenetic mechanisms in nanomaterial-induced toxicity10.2217/epi.15.3 ↗
80. Nanomedicine and epigenome. possible health risks10.1016/j.fct.2017.07.020 ↗
81. Carbon nanotube- and asbestos-induced DNA and RNA methylation changes in bronchial epithelial cells10.1021/acs.chemrestox.8b00406 ↗
82. Changes in DNA methylation in mouse lungs after a single intra-tracheal administration of nanomaterials10.1371/journal.pone.0169886 ↗
83. Gold nanoparticles-induced cytotoxicity in triple negative breast cancer involves different epigenetic alterations depending upon the surface charge10.1038/s41598-018-30541-3 ↗
84. Low-dose carbon-based nanoparticle-induced effects in A549 lung cells determined by biospectroscopy are associated with increases in genomic methylation10.1038/srep20207 ↗
85. Epigenetic modulation upon exposure of lung fibroblasts to TiO2 and ZnO nanoparticles: alterations in DNA methylation10.2147/IJN.S110390 ↗
86. DNA methylation changes in human lung epithelia cells exposed to multi-walled carbon nanotubes10.1080/17435390.2017.1371350 ↗
87. Characterization and DNA methylation modulatory activity of gold nanoparticles synthesized by Pseudoalteromonas strain10.1007/s12038-018-9842-6 ↗
88. Titanium dioxide aggregating nanoparticles induce autophagy and under-expression of microRNA 21 and 30a in A549 cell line: a comparative study with cobalt(II, III) oxide nanoparticles10.1016/j.tiv.2017.04.007 ↗
89. Prolonged effects of silver nanoparticles on p53/p21 pathway-mediated proliferation, DNA damage response, and methylation parameters in HT22 hippocampal neuronal cells10.1007/s12035-016-9688-6 ↗
90. Silver nanoparticle-induced hemoglobin decrease involves alteration of histone 3 methylation status10.1016/j.biomaterials.2015.08.015 ↗
91. Multi-omics analysis of ten carbon nanomaterials effects highlights cell type specific patterns of molecular regulation and adaptation10.1016/j.impact.2018.05.003 ↗
92. TGF-beta1 mediated MAPK signaling pathway promotes collagen formation induced by Nano NiO in A549 cells10.1002/tox.22738 ↗
93. Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line10.1016/j.tiv.2010.01.001 ↗
94. Nanotoxicity: an interplay of oxidative stress, inflammation and cell death10.3390/nano5031163 ↗
95. Epigenetics and oxidative stress in aging
96. Signaling epigenetics: novel insights on cell signaling and epigenetic regulation10.1002/iub.557 ↗
97. Epigenetic mechanisms involved in modulation of inflammatory diseases
98. (ROS)-Based Nanomedicine10.1021/acs.chemrev.8b00626 ↗
99. The redox basis of epigenetic modifications: from mechanisms to functional consequences10.1089/ars.2010.3492 ↗
100. The oxidative stress theory of disease: levels of evidence and epistemological aspects10.1111/bph.13544 ↗